Cantabio Pharmaceuticals, Inc.
Cantabio Pharmaceuticals, Inc. (CTBO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTBO · as of Jun 9, 2026
Key Statistics
Explore Cantabio Pharmaceuticals, Inc. Data
ctbo stock data · financialsCompetitors & Peers
ctbo competitorsCTBO
DGCRF
GNBT
HGENQ
NLBS
NMMCFStock Performance
Full HistoryAbout Cantabio Pharmaceuticals, Inc.
Cantabio Pharmaceuticals, Inc. is a preclinical biotechnology company dedicated to the discovery, development, and commercialization of innovative therapeutic solutions for Parkinson's disease (PD), A…
what is cantabio pharmaceuticals, inc. · ctbo stock overview · cantabio pharmaceuticals, inc. company profile · who is cantabio pharmaceuticals, inc. ceo · ctbo OTC · cantabio pharmaceuticals, inc. headquarters · cantabio pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Cantabio Pharmaceuticals, Inc. (CTBO) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 16, 2015. As of the latest trading session, CTBO stock price is $1.01, with a market capitalization of $22,769. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, Cantabio Pharmaceuticals, Inc. (CTBO) stock price is $1.01. The stock is traded on OTC under the ticker symbol CTBO. The 52-week range is $1.01 – $1.01.